Steady state assessment [Regulatives / Guidelines]

posted by kram – India, 2010-02-15 16:16 (5604 d 19:24 ago) – Posting: # 4764
Views: 5,837

(edited on 2010-02-16 05:24)

Dear HS,

according to your post i hav some doubts, please guide me...

❝ Generally, three successive CMIN values should be provided to verify that steady-state conditions have been achieved.


Here, is it three successive CMIN values means last Three pre dose values ?

❝ Although CMIN most frequently occurs immediately prior to the next successive dose, situations do occur with CMIN observed subsequent to dosing.


But Cmin occurs in between Last dose and AUCtau then how above statement is possible ?

To determine a steady state concentration, the CMIN values should be regressed over time and the resultant slope should be tested for its difference from zero.


If I have performed ANOVA (using last three pre dose values (time point x, y, z) and result (p-value=0.3241) shows there is no significant difference between three pre dose values.
And for same study I have regressed Cmin over Tmin and resultant slope tested for its difference from zero and result shows (p-value = 0.0219), slope is different from zero.

From above both result shall I conclude that steady state achieved after (or at) time point x?


Thanks and Regards,

Ram

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
87 visitors (0 registered, 87 guests [including 53 identified bots]).
Forum time: 12:40 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5